Both in Biotechnology
Candel Therapeutics vs Entera Bio
Over the past year CADL returned +69.0% and ENTX returned +7.4%; their daily moves had a correlation of 0.18.
CADL +69.0% ENTX +7.4%Growth of $1, one year, split-adjusted
| Metric | CADL | ENTX |
|---|---|---|
| Price | $8.82 | $3.05 |
| Market cap | $674.9M | $530.5M |
| Today | +8.62% | −1.29% |
| 1 month | −13.8% | +16.4% |
| 6 months | +15.0% | +162.9% |
| Year to date | +56.1% | +57.2% |
| 1 year | +63.9% | +4.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $153.7M | $11.0M |
| Dividend yield | — | — |
| Volatility (60d) | 67.6% | 61.2% |
| Short % of float | 21.5% | 3.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).